Concizumab (Anti-TFPI)

Ask the supplier | View on supplier's website

Concizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2337
Sku #	A2337-1mg*5
Pricing	1mg*5, $970.00

Feedback